Advisors Asset Management, Inc. Acadia Pharmaceuticals Inc Transaction History
Advisors Asset Management, Inc.
- $5.23 Billion
- Q4 2024
A detailed history of Advisors Asset Management, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 20,852 shares of ACAD stock, worth $355,943. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,852
Previous 21,087
1.11%
Holding current value
$355,943
Previous $324,000
17.9%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding ACAD
# of Institutions
315Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$732 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$206 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$149 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$125 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.76B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...